Sigilon Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021

CAMBRIDGE, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living Therapeutics™ platform, today announced that its President and Chief Executive Officer, Rogerio Vivaldi, M.D., will present a corporate overview during the 39th Annual J.P. Morgan Healthcare Conference. The presentation will take place on Thursday, January 14 at 3:40 p.m. EST, in a virtual format. Published on : http://www.globenewswire.com/news-release/2021/01/13/2157756/0/en/Sigilon-Therapeutics-to-Present-at-the-39th-Annual-J-P-Morgan-Healthcare-Conference-on-January-14-2021.html…

More